Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Refractory Graft-Versus-Host Disease”

126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 126 results

Early research (Phase 1)Ended earlyNCT04070781
What this trial is testing

Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Refractory GVHDGraft Vs Host Disease
Columbia University 1
Early research (Phase 1)Study completedNCT00760981
What this trial is testing

A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
David Miklos 15
Early research (Phase 1)Study completedNCT01596218
What this trial is testing

Brentuximab Vedotin for Steroid Refractory GvHD

Who this might be right for
Graft vs. Host Disease
Massachusetts General Hospital 35
Large-scale testing (Phase 3)Study completedNCT00179855
What this trial is testing

Extracorporeal Photopheresis for Acute Graft Versus Host Disease

Who this might be right for
Graft Versus Host DiseaseCancerStem Cell Transplantation
Ann & Robert H Lurie Children's Hospital of Chicago 10
Large-scale testing (Phase 3)Ended earlyNCT02524847
What this trial is testing

Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Refractory Acute Graft Versus Host Disease
Therakos, Inc., a Mallinckrodt Company 29
Testing effectiveness (Phase 2)Study completedNCT02841995
What this trial is testing

Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Kadmon, a Sanofi Company 54
Not applicableLooking for participantsNCT07184853
What this trial is testing

Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

Who this might be right for
Graft vs Host Disease
First Affiliated Hospital of Zhejiang University 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06677255
What this trial is testing

A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease
Wuhan Optics Valley Vcanbiopharma Co., Ltd. 149
Early research (Phase 1)Study completedNCT03158896
What this trial is testing

Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease
University of Kansas Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00003894
What this trial is testing

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Who this might be right for
Graft Versus Host DiseaseUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 36
Early research (Phase 1)Ended earlyNCT02086513
What this trial is testing

Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT

Who this might be right for
Graft Versus Host Disease
Massachusetts General Hospital 17
Post-approval studies (Phase 4)Study completedNCT00574470
What this trial is testing

Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD

Who this might be right for
Graft vs Host Disease
University of Iowa 3
Early research (Phase 1)Study completedNCT01672229
What this trial is testing

Bortezomib in Patients With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Mehrdad Abedi, MD 16
Testing effectiveness (Phase 2)Study completedNCT04926194
What this trial is testing

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative NeoplasmSteroid Refractory GVHDAllogeneic Hematopoietic Cell Transplant
University Health Network, Toronto 1
Not applicableNo Longer AvailableNCT03172455
What this trial is testing

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Acute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more
Impatients N.V. trading as myTomorrows
Not applicableStudy completedNCT05052385
What this trial is testing

ECP Combination Study

Who this might be right for
Steroid Refractory GVHD
European Society for Blood and Marrow Transplantation 319
Testing effectiveness (Phase 2)UnknownNCT02385019
What this trial is testing

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Graft vs Host Disease
Instituto de Medicina Molecular João Lobo Antunes 22
Large-scale testing (Phase 3)Looking for participantsNCT06615050
What this trial is testing

Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 572
Early research (Phase 1)Study completedNCT01155817
What this trial is testing

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Who this might be right for
Bone Marrow Transplant FailureLymphoma, Non-HodgkinLymphoma, T-Cell, Peripheral
Stanford University 33
Large-scale testing (Phase 3)Study completedNCT00366145
What this trial is testing

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft Versus Host Disease
Mesoblast, Inc. 260
Next Page